Targeted Literature Review to Describe Safety Outcomes in Immune Thrombocytopenia Patients Treated With Thrombopoietin-Receptor AgonistsFirst published 04/11/2019 Last updated 23/04/2024 EU PAS number: EUPAS32139StudyFinalised